These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7251507)

  • 1. Chemical modifications in the tetracycline series.
    Valcavi U; Brandt A; Corsi GB; Minoja F; Pascucci G
    J Antibiot (Tokyo); 1981 Jan; 34(1):34-9. PubMed ID: 7251507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in tetracycline antibiotics.
    Sum PE; Sum FW; Projan SJ
    Curr Pharm Des; 1998 Apr; 4(2):119-32. PubMed ID: 10197036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure-activity correlations in the tetracycline family].
    Fourtillan JB; Lefèbvre MA
    Nouv Presse Med; 1980 Jan; 9(21 Suppl):64-70. PubMed ID: 7355087
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetracyclines: chemistry, biochemistry, and structure-activity relations.
    Dürckheimer W
    Angew Chem Int Ed Engl; 1975 Nov; 14(11):721-34. PubMed ID: 812385
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 8-aminomethyltetracycline derivatives as novel antibacterial agents.
    Clark RB; He M; Deng Y; Sun C; Chen CL; Hunt DK; O'Brien WJ; Fyfe C; Grossman TH; Sutcliffe JA; Achorn C; Hogan PC; Katz CE; Niu J; Zhang WY; Zhu Z; Ronn M; Xiao XY
    J Med Chem; 2013 Oct; 56(20):8112-38. PubMed ID: 24047201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.
    Nelson ML; Park BH; Andrews JS; Georgian VA; Thomas RC; Levy SB
    J Med Chem; 1993 Feb; 36(3):370-7. PubMed ID: 8426364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering.
    Lešnik U; Lukežič T; Podgoršek A; Horvat J; Polak T; Šala M; Jenko B; Harmrolfs K; Ocampo-Sosa A; Martínez-Martínez L; Herron PR; Fujs Š; Kosec G; Hunter IS; Müller R; Petković H
    Angew Chem Int Ed Engl; 2015 Mar; 54(13):3937-40. PubMed ID: 25650563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 9-substituted tetracycline derivatives.
    Koza DJ; Nsiah YA
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2163-5. PubMed ID: 12127528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing.
    Barry AL; Draper DL; Wong MK
    Am J Clin Pathol; 1978 Nov; 70(5):821-5. PubMed ID: 717289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
    Sum PE; Lee VJ; Testa RT; Hlavka JJ; Ellestad GA; Bloom JD; Gluzman Y; Tally FP
    J Med Chem; 1994 Jan; 37(1):184-8. PubMed ID: 8289194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatile and facile synthesis of diverse semisynthetic tetracycline derivatives via Pd-catalyzed reactions.
    Nelson ML; Ismail MY; McIntyre L; Bhatia B; Viski P; Hawkins P; Rennie G; Andorsky D; Messersmith D; Stapleton K; Dumornay J; Sheahan P; Verma AK; Warchol T; Levy SB
    J Org Chem; 2003 Jul; 68(15):5838-51. PubMed ID: 12868916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of tetracycline ring A analogs.
    Moskalyk RE; Mak AL; Chatten LG; Locock RA
    J Pharm Sci; 1981 May; 70(5):496-500. PubMed ID: 7241350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens.
    Jones RN; Stilwell MG; Wilson ML; Mendes RE
    Diagn Microbiol Infect Dis; 2013 May; 76(1):69-72. PubMed ID: 23490012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of 2d generation tetracyclines. Pharmacokinetic behavior].
    Fourtillan JB; Saux MC
    Sem Hop; 1978 Feb; 54(4):224-30. PubMed ID: 208173
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of eight tetracyclines on growth and lipase formation of Staphylococcus aureus.
    Mates A
    Microbios; 1974; 10A SUPPL(41):105-10. PubMed ID: 4218293
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
    Xiao XY; Hunt DK; Zhou J; Clark RB; Dunwoody N; Fyfe C; Grossman TH; O'Brien WJ; Plamondon L; Rönn M; Sun C; Zhang WY; Sutcliffe JA
    J Med Chem; 2012 Jan; 55(2):597-605. PubMed ID: 22148514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative activity of tetracycline, doxycycline and minocycline against Haemophilus].
    Dabernat H; Delmas C; Bauriaud R; Lareng MB
    Pathol Biol (Paris); 1983 May; 31(5):413-8. PubMed ID: 6353333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterocyclyl tetracyclines. 2. 7-Methoxy-8-pyrrolidinyltetracyclines: discovery of TP-2758, a potent, orally efficacious antimicrobial against Gram-negative pathogens.
    Sun C; Deng Y; Hunt DK; Fyfe C; Chen CL; Clark RB; Grossman TH; Sutcliffe JA; Xiao XY
    J Antibiot (Tokyo); 2018 Feb; 71(2):287-297. PubMed ID: 28743974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria.
    Nelson ML; Park BH; Levy SB
    J Med Chem; 1994 Apr; 37(9):1355-61. PubMed ID: 8176712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli.
    Chopra I; Shales S; Ball P
    J Gen Microbiol; 1982 Apr; 128(4):689-92. PubMed ID: 6750037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.